TWI367755B - Film coated product - Google Patents

Film coated product

Info

Publication number
TWI367755B
TWI367755B TW095117776A TW95117776A TWI367755B TW I367755 B TWI367755 B TW I367755B TW 095117776 A TW095117776 A TW 095117776A TW 95117776 A TW95117776 A TW 95117776A TW I367755 B TWI367755 B TW I367755B
Authority
TW
Taiwan
Prior art keywords
film coated
coated product
product
film
coated
Prior art date
Application number
TW095117776A
Other languages
Chinese (zh)
Other versions
TW200719891A (en
Inventor
Takeshi Hamaura
Susumu Hasegawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200719891A publication Critical patent/TW200719891A/en
Application granted granted Critical
Publication of TWI367755B publication Critical patent/TWI367755B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095117776A 2005-05-20 2006-05-19 Film coated product TWI367755B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005147436 2005-05-20

Publications (2)

Publication Number Publication Date
TW200719891A TW200719891A (en) 2007-06-01
TWI367755B true TWI367755B (en) 2012-07-11

Family

ID=37431333

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095117776A TWI367755B (en) 2005-05-20 2006-05-19 Film coated product

Country Status (5)

Country Link
JP (1) JP5000491B2 (en)
KR (1) KR101318032B1 (en)
CN (1) CN101171006B (en)
TW (1) TWI367755B (en)
WO (1) WO2006123765A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008050714A1 (en) * 2006-10-25 2008-05-02 Daiichi Sankyo Company, Limited Packaging material
KR101665705B1 (en) * 2006-12-07 2016-10-12 다이이찌 산쿄 가부시키가이샤 Film-coated preparation having improved stability
TWI414310B (en) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd Elution-improved pharmaceutical preparation
TW200833325A (en) * 2006-12-26 2008-08-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising ascorbic acid
JPWO2009057569A1 (en) * 2007-10-29 2011-03-10 第一三共株式会社 Film coating formulation
JP5688799B2 (en) * 2008-08-11 2015-03-25 第一三共株式会社 Odor control method
JP5886530B2 (en) * 2010-02-26 2016-03-16 第一三共株式会社 tablet
US9381248B2 (en) 2010-08-31 2016-07-05 Toray Industries, Inc. Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
CN102028663B (en) * 2010-12-14 2011-11-30 北京万生药业有限责任公司 Stable olmesartan medoxomil solid preparation
WO2012174731A1 (en) * 2011-06-24 2012-12-27 Cheng Haiyung Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
TWI461215B (en) * 2011-06-24 2014-11-21 Acenda Pharma Inc Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
JP5744340B2 (en) * 2013-05-24 2015-07-08 持田製薬株式会社 Film coating composition
JP6653116B2 (en) * 2014-08-27 2020-02-26 日本ケミファ株式会社 Olmesartan prodrug formulations
JP6360007B2 (en) * 2015-06-12 2018-07-18 富士フイルム株式会社 Method for producing drug-containing particles
EP3434284A4 (en) * 2016-03-24 2019-11-13 Daiichi Sankyo Company, Limited Medicine for treating renal disease
KR102103530B1 (en) * 2018-06-29 2020-04-22 주식회사 코피텍 Composition for film-coating and tablet coated with the composition
CN114522146A (en) * 2022-01-21 2022-05-24 上海睿奕生物科技有限公司 White titanium-free film coating material and preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
EP1058543A1 (en) * 1998-12-31 2000-12-13 Hercules Incorporated Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings
EP1240174A2 (en) * 1999-12-22 2002-09-18 Metabasis Therapeutics, Inc. Novel bisamidate phosphonate prodrugs
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
JP4107831B2 (en) * 2000-11-21 2008-06-25 第一三共株式会社 Pharmaceutical composition
ES2262689T3 (en) * 2000-11-21 2006-12-01 Sankyo Company, Limited COMPOSITION CONTAINING AN ANTIGONIST OF THE ANGIOTENSIN II RECEPTOR AND A DIURETIC AND ITS USE FOR THE TREATMENT OF HYPERTENSION.
JP4647851B2 (en) * 2001-08-07 2011-03-09 日立マクセル株式会社 The camera module
BRPI0406987A (en) * 2003-01-31 2006-01-10 Sankyo Co Medicament for the prevention and / or treatment of atherosclerosis, medicaments for inhibiting vascular smooth muscle cell proliferation, neointimal formation of blood vessels and vascular remodeling, medicament for the prevention of restenosis following percutaneous coronary intervention, and, medicines for the prophylaxis and / or treatment of hypertension or diseases caused by hypertension or diseases caused by hypertension, heart disease, angina pectoris, myocardial infarction, arrhythmia, sudden death, heart failure, cardiac hypertrophy, kidney diseases, diabetic nephropathy, glomerulonephritis, nephrosclerosis, cerebrovascular diseases, cerebral infarction, and cerebral hemorrhage
JP5248733B2 (en) * 2003-11-28 2013-07-31 エスエス製薬株式会社 Volatilization-preventing solid preparation and method for producing the same

Also Published As

Publication number Publication date
WO2006123765A1 (en) 2006-11-23
TW200719891A (en) 2007-06-01
CN101171006B (en) 2010-12-01
KR20080011394A (en) 2008-02-04
CN101171006A (en) 2008-04-30
KR101318032B1 (en) 2013-10-14
JP5000491B2 (en) 2012-08-15
JPWO2006123765A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
TWI367755B (en) Film coated product
EP1862186A4 (en) Adhesion-preventive film
EP2074184B8 (en) Coated article
HK1124877A1 (en) Badge- and bpa-free can coating
EP1876035A4 (en) Transfer film
TWI341558B (en) Coating film forming method
GB0614545D0 (en) Coating Film
GB0625177D0 (en) Coating material
GB2428958B (en) Snackfood product
PL1989044T3 (en) Packaging film
EP1866100A4 (en) Film forming equipment
PT1876916E (en) Product
GB0507310D0 (en) Tape dispenser
IL183268A0 (en) Ferromagnetic-backed film
ZA200706043B (en) Multilayer film
GB2424849B (en) Film for packaging
GB0524520D0 (en) Product
GB0504589D0 (en) Product
EP1912629A4 (en) Asymmetrically coated tablet
GB0515480D0 (en) Product
GB2415659B (en) Film for packaging
GB0519320D0 (en) Film for packaging
GB0625171D0 (en) Film
ZA200703106B (en) Coated packaging materials
GB0508856D0 (en) Film